BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2966574)

  • 21. Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume paracentesis.
    Salerno F; Badalamenti S; Moser P; Lorenzano E; Incerti P; Dioguardi N
    Gastroenterology; 1990 Apr; 98(4):1063-70. PubMed ID: 2138104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Reaction of the cardiovascular and humoral system to acute hypervolemia in patients with liver cirrhosis].
    Kozáková M; Tesar V; Petrtýl J; Horký K; Kordac V
    Cas Lek Cesk; 1989 Feb; 128(6):168-73. PubMed ID: 2524257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyponatremia of cirrhosis: role of vasopressin and decreased 'effective' plasma volume.
    Akriviadis EA; Ervin MG; Cominelli F; Fisher DA; Reynolds TB
    Scand J Gastroenterol; 1997 Aug; 32(8):829-34. PubMed ID: 9282977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems.
    Saló J; Guevara M; Fernández-Esparrach G; Bataller R; Ginès A; Jimenez W; Ginès P; Rivera F; Arroyo V; Rodés J
    Hepatology; 1997 Jun; 25(6):1338-42. PubMed ID: 9185749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial.
    Degoricija V; Zjacic-Rotkvic V; Marout J; Sefer S; Troskot B
    Croat Med J; 2003 Apr; 44(2):178-86. PubMed ID: 12698509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial natriuretic peptide: renal effects in cirrhosis of the liver.
    Levy M
    Semin Nephrol; 1997 Nov; 17(6):520-9. PubMed ID: 9353863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variability of atrial natriuretic peptide plasma levels in ascitic cirrhotics: pathophysiological and clinical implications.
    Angeli P; Caregaro L; Menon F; Sacerdoti D; De Toni R; Merkel C; Gatta A
    Hepatology; 1992 Dec; 16(6):1389-94. PubMed ID: 1446894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of changes in intravascular volume on atrial size and plasma levels of immunoreactive atrial natriuretic peptide in uremic man.
    Cannella G; Albertini A; Assanelli D; Ghielmi S; Poiesi C; Gaggiotti M; Sandrini M; Visioli O; Maiorca R
    Clin Nephrol; 1988 Oct; 30(4):187-92. PubMed ID: 2975201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of atrial natriuretic peptide resistance by increasing distal tubular sodium delivery in patients with decompensated cirrhosis.
    Abraham WT; Lauwaars ME; Kim JK; Peña RL; Schrier RW
    Hepatology; 1995 Sep; 22(3):737-43. PubMed ID: 7657277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation.
    Engelmann MD; Niemann L; Kanstrup IL; Skagen K; Godtfredsen J
    Int J Cardiol; 2005 Oct; 105(1):31-9. PubMed ID: 16207542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension.
    Buckley MG; Markandu ND; Miller MA; Sagnella GA; MacGregor GA
    J Hum Hypertens; 1993 Jun; 7(3):245-50. PubMed ID: 8345491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial natriuretic peptide in liver cirrhosis with mild ascites.
    Miyase S; Fujiyama S; Chikazawa H; Sato T
    Gastroenterol Jpn; 1990 Jun; 25(3):356-62. PubMed ID: 2162795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of atrial natriuretic peptide in the renal response to acute volume expansion in the normal and essential hypertensive patient].
    Mimran A; Nussberger J; Ribstein J; Waeber B; Brunner HR
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():101-4. PubMed ID: 2973295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial natriuretic factor in the ascitic fluid of cirrhotic patients.
    Vesely DL; Winters CJ
    J Med; 1989; 20(3-4):208-16. PubMed ID: 2530296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human atrial natriuretic peptide (ANP) for the treatment of patients with liver cirrhosis and ascites.
    Brabant G; Jüppner H; Kirschner M; Böker K; Schmidt FW; Hesch RD
    Klin Wochenschr; 1986; 64 Suppl 6():108-11. PubMed ID: 2948056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrial natriuretic peptide (ANP) responsiveness in patients with hypothyroidism.
    Barna I; Földes J; Tóth M; Büki B; Lang RE; De Châtel R
    Acta Med Hung; 1994; 50(1-2):23-32. PubMed ID: 7638038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natriuretic peptides in patients with atrial fibrillation.
    Wozakowska-Kapłon B; Opolski G; Herman Z; Kosior D
    Cardiol J; 2008; 15(6):525-9. PubMed ID: 19039756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscle sympathetic nerve activity and renal responsiveness to atrial natriuretic factor during the development of hepatic ascites.
    Morali GA; Floras JS; Legault L; Tobe S; Skorecki KL; Blendis LM
    Am J Med; 1991 Oct; 91(4):383-92. PubMed ID: 1835288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperresponsiveness to water immersion in sodium retaining cirrhotics: the role of atrial natriuretic factor.
    Campbell PJ; Leung WM; Logan AG; Debowski TE; Blendis LM; Skorecki KL
    Clin Invest Med; 1988 Dec; 11(6):392-5. PubMed ID: 2976331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Renal, hemodynamic and hormonal effects of repeated water immersion in liver cirrhosis].
    Christoph C; Held C; Scholze HJ
    Gastroenterol J; 1990; 50(4):183-6. PubMed ID: 2151113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.